Safety and Efficacy of Wireless pH Monitoring in Patients Suspected of Gastroesophageal Reflux Disease
- 1 October 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 51 (9) , 777-788
Abstract
Introduction: The primary aim of this systematic review was to determine the safety, technical efficacy, and effectiveness of 48-hour wireless pH monitoring (WM) for gastroesophageal reflux disease (GERD), compared with no pH monitoring in patients who failed to tolerate a catheter. In the absence of eligible studies, the secondary aim was to determine these performance characteristics for WM relative to catheter-based pH monitoring (CBM) in patients suspected of GERD, who are able to tolerate a catheter. Methods: A protocol was registered on the PROSPERO database (CRD42013005852) before conducting the systematic review, which included the study selection criteria, and critical appraisal methods. Several key databases were searched to identify eligible comparative studies. Results: Chest pain occurred more often with WM compared with CBM; however, other adverse events were reported less frequently with WM. Technical failures, mostly due to attachment failures and early capsule detachments, were 3 times higher with WM, compared with CBM, [pooled relative risk (from meta-analysis)=3.3; 95% confidence interval, 1.63-6.81; I 2=0%; P=0.012; k=8). The sensitivity and specificity of WM varied widely, depending on type of analysis, monitoring time, capsule placement, reference standard, and diagnostic threshold. Discussion: WM is usually better tolerated than CBM but has more technical problems. Test accuracy was highly variable between studies; therefore, conclusions could not be drawn regarding the performance of the 2 tests. To make meaningful comparisons between WM and CBM a consensus is needed on the diagnostic threshold for GERD, monitoring time, appropriate capsule positioning, and the reference standard.Keywords
This publication has 43 references indexed in Scilit:
- Many Patients Continue Using Proton Pump Inhibitors After Negative Results From Tests for Reflux DiseaseClinical Gastroenterology and Hepatology, 2012
- Unsedated peroral wireless pH capsule placement vs. standard pH testing: A randomized study and cost analysisBMC Gastroenterology, 2012
- Bravo 48-hour Wireless pH Monitoring in Patients With Non-cardiac Chest Pain. Objective Gastroesophageal Reflux Disease Parameters Predict the Responses to Proton Pump InhibitorsJournal of Neurogastroenterology and Motility, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Comparison of the Impact of Wireless Versus Catheter-based pH-metry on Daily Activities and Study-related SymptomsJournal of Clinical Gastroenterology, 2011
- To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non‐erosive gastroesophageal reflux disease in a multiracial Asian cohortJournal of Digestive Diseases, 2010
- Tolerability and Clinical Utility of the Bravo pH Capsule in ChildrenJournal of Clinical Gastroenterology, 2009
- Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence'BMC Medical Research Methodology, 2009
- Gastroesophageal Reflux DiseaseNew England Journal of Medicine, 2008
- Ambulatory pH: monitoring with a wireless systemSurgical Endoscopy, 2007